Abstract
The aim of this thesis was to identify and validate biomarkers in esophagogastric cancer (EC) to help guide clinical practice.
In the first part of the thesis, we investigated the currently used biomarker HER2, aiming to improve the treatment for HER2-positive EC patients. We found that applying a strict definition of HER2 status increases the likelihood of
In the first part of the thesis, we investigated the currently used biomarker HER2, aiming to improve the treatment for HER2-positive EC patients. We found that applying a strict definition of HER2 status increases the likelihood of
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 21 Oct 2024 |
| Print ISBNs | 9789464962024 |
| Publication status | Published - 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Biomarkers in gastro-esophageal cancer: From bedside to bench and back'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver